Cargando…

Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial

BACKGROUND: Management of intermittent claudication should include secondary prevention to reduce the risk of cardiocerebrovascular disease. Patient adherence to secondary prevention is a challenge. The aim of this study was to investigate whether a person-centred, nurse-led follow-up programme coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Haile, Sara T, Joelsson-Alm, Eva, Johansson, Unn Britt, Lööf, Helena, Palmer-Kazen, Ulrika, Gillgren, Peter, Linné, Anneli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364713/
https://www.ncbi.nlm.nih.gov/pubmed/35848783
http://dx.doi.org/10.1093/bjs/znac241
_version_ 1785076901849595904
author Haile, Sara T
Joelsson-Alm, Eva
Johansson, Unn Britt
Lööf, Helena
Palmer-Kazen, Ulrika
Gillgren, Peter
Linné, Anneli
author_facet Haile, Sara T
Joelsson-Alm, Eva
Johansson, Unn Britt
Lööf, Helena
Palmer-Kazen, Ulrika
Gillgren, Peter
Linné, Anneli
author_sort Haile, Sara T
collection PubMed
description BACKGROUND: Management of intermittent claudication should include secondary prevention to reduce the risk of cardiocerebrovascular disease. Patient adherence to secondary prevention is a challenge. The aim of this study was to investigate whether a person-centred, nurse-led follow-up programme could improve adherence to medication compared with standard care. METHODS: A non-blinded RCT was conducted at two vascular surgery centres in Sweden. Patients with intermittent claudication and scheduled for revascularization were randomized to the intervention or control (standard care) follow-up programme. The primary outcome, adherence to prescribed secondary preventive medication, was based on registry data on dispensed medication and self-reported intake of medication. Secondary outcomes were risk factors for cardiocerebrovascular disease according to the Framingham risk score. RESULTS: Some 214 patients were randomized and analysed on an intention-to-treat basis. The mean proportion of days covered (PDC) at 1 year for lipid-modifying agents was 79 per cent in the intervention and 82 per cent in the control group, whereas it was 92 versus 91 per cent for antiplatelet and/or anticoagulant agents. The groups did not differ in mean PDC (lipid-modifying P = 0.464; antiplatelets and/or anticoagulants P = 0.700) or in change in adherence over time. Self-reported adherence to prescribed medication was higher than registry-based adherence regardless of allocation or medication group (minimum P < 0.001, maximum P = 0.034). There was no difference in median Framingham risk score at 1 year between the groups. CONCLUSION: Compared with the standard follow-up programme, a person-centred, nurse-led follow-up programme did not improve adherence to secondary preventive medication. Adherence was overestimated when self-reported compared with registry-reported.
format Online
Article
Text
id pubmed-10364713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103647132023-07-31 Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial Haile, Sara T Joelsson-Alm, Eva Johansson, Unn Britt Lööf, Helena Palmer-Kazen, Ulrika Gillgren, Peter Linné, Anneli Br J Surg Randomized Clinical Trial BACKGROUND: Management of intermittent claudication should include secondary prevention to reduce the risk of cardiocerebrovascular disease. Patient adherence to secondary prevention is a challenge. The aim of this study was to investigate whether a person-centred, nurse-led follow-up programme could improve adherence to medication compared with standard care. METHODS: A non-blinded RCT was conducted at two vascular surgery centres in Sweden. Patients with intermittent claudication and scheduled for revascularization were randomized to the intervention or control (standard care) follow-up programme. The primary outcome, adherence to prescribed secondary preventive medication, was based on registry data on dispensed medication and self-reported intake of medication. Secondary outcomes were risk factors for cardiocerebrovascular disease according to the Framingham risk score. RESULTS: Some 214 patients were randomized and analysed on an intention-to-treat basis. The mean proportion of days covered (PDC) at 1 year for lipid-modifying agents was 79 per cent in the intervention and 82 per cent in the control group, whereas it was 92 versus 91 per cent for antiplatelet and/or anticoagulant agents. The groups did not differ in mean PDC (lipid-modifying P = 0.464; antiplatelets and/or anticoagulants P = 0.700) or in change in adherence over time. Self-reported adherence to prescribed medication was higher than registry-based adherence regardless of allocation or medication group (minimum P < 0.001, maximum P = 0.034). There was no difference in median Framingham risk score at 1 year between the groups. CONCLUSION: Compared with the standard follow-up programme, a person-centred, nurse-led follow-up programme did not improve adherence to secondary preventive medication. Adherence was overestimated when self-reported compared with registry-reported. Oxford University Press 2022-07-15 /pmc/articles/PMC10364713/ /pubmed/35848783 http://dx.doi.org/10.1093/bjs/znac241 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Randomized Clinical Trial
Haile, Sara T
Joelsson-Alm, Eva
Johansson, Unn Britt
Lööf, Helena
Palmer-Kazen, Ulrika
Gillgren, Peter
Linné, Anneli
Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title_full Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title_fullStr Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title_full_unstemmed Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title_short Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
title_sort effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial
topic Randomized Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364713/
https://www.ncbi.nlm.nih.gov/pubmed/35848783
http://dx.doi.org/10.1093/bjs/znac241
work_keys_str_mv AT hailesarat effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT joelssonalmeva effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT johanssonunnbritt effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT loofhelena effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT palmerkazenulrika effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT gillgrenpeter effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial
AT linneanneli effectsofapersoncentrednurseledfollowupprogrammeonadherencetoprescribedmedicationamongpatientssurgicallytreatedforintermittentclaudicationrandomizedclinicaltrial